Editing Peritoneal dialysis

{{Short description|Blood purification procedure using the abdominal peritoneum}}
{{cs1 config|name-list-style=vanc}}
{{Infobox medical intervention
| Name       = Peritoneal dialysis
| Image      = Peritoneal_dialysis.gif
| Caption    = Diagram of peritoneal dialysis
| ICD10      =
| ICD9       = {{ICD9proc|54.98}}
| MeshID     = D010530
| OPS301     =
| OtherCodes =}}
'''Peritoneal dialysis''' ('''PD''') is a type of [[kidney dialysis|dialysis]] that uses the [[peritoneum]] in a person's [[abdomen]] as the membrane through which fluid and dissolved substances are exchanged with the [[blood]].<ref>{{Cite journal |last1=Perl |first1=Jeffrey |last2=Bargman |first2=Joanne M. |date=2016-11-01 |title=Peritoneal dialysis: from bench to bedside and bedside to bench |journal=American Journal of Physiology. Renal Physiology |volume=311 |issue=5 |pages=F999–F1004 |doi=10.1152/ajprenal.00012.2016 |pmid=27009336 |issn=1931-857X|doi-access=free }}</ref><ref>{{cite book| vauthors = Billings DM |chapter=28. The client with urinary tract health problems §Dialysis |title=Lippincott's Content Review for NCLEX-RN|publisher=Lippincott Williams & Wilkins|isbn=978-1-58255-515-7|page=575|chapter-url=https://books.google.com/books?id=VYRYpls_92oC&pg=PA575|language=en|url-status=live|archive-url=https://web.archive.org/web/20170113134140/https://books.google.ca/books?id=VYRYpls_92oC&pg=PA575|archive-date=2017-01-13|date=2008-11-01}}</ref> It is used to remove excess fluid, correct [[electrolyte problems]], and remove toxins in those with [[kidney failure]].<ref name=WHO2008/> Peritoneal dialysis has better outcomes than [[hemodialysis]] during the first two years.<ref name="Lim_2016"/> Other benefits include greater flexibility and better tolerability in those with significant [[heart disease]].<ref name="Lim_2016"/>

== Side effects ==
Complications may include [[peritonitis|infections within the abdomen]], [[hernia]]s, [[high blood sugar]], bleeding in the abdomen, and blockage of the catheter.<ref name=WHO2008/> Peritoneal dialysis is not possible in those with significant prior [[abdominal surgery]] or [[inflammatory bowel disease]].<ref name=WHO2008/> It requires some degree of technical skill to be done properly.<ref name="Lim_2016"/>

== Mechanism ==
[[File:Dívka s peritoneální dialýzou.jpg|thumb|A young woman using an automated peritoneal dialysis machine.]]
In peritoneal dialysis, a specific solution is introduced and then removed through a permanent tube in the lower abdomen.<ref name=WHO2008/> This may occur either at regular intervals throughout the day known as continuous ambulatory peritoneal dialysis (CAPD), or at night with the assistance of a machine known as automated peritoneal dialysis (APD),<ref name=WHO2008/> or continuous cycling peritoneal dialysis (CCPD).<ref name=MayoClinicPD>{{cite web|url=https://www.mayoclinic.org/tests-procedures/peritoneal-dialysis/about/pac-20384725#:~:text=Continuous%20cycling%20peritoneal%20dialysis%20(CCPD),-Another%20name%20for&text=This%20method%20uses%20a%20machine,you%20empty%20in%20the%20morning.
|title=Peritoneal Dialysis: Continuous cycling peritoneal dialysis (CCPD)
|publisher=The [[Mayo Clinic]]|author=Mayo Clinic Staff|date=May 2, 2023
|accessdate=2024-06-20}}</ref> 

The solution is typically made of [[sodium chloride]], [[bicarbonate]], and an [[osmotic agent]]. <ref name="WHO2008">{{cite book | title = WHO Model Formulary 2008 | year = 2009 | isbn = 978-92-4-154765-9 | vauthors = ((World Health Organization)) | veditors = Stuart MC, Kouimtzi M, Hill SR | hdl = 10665/44053 | author-link = World Health Organization | publisher = World Health Organization | page=453 | hdl-access=free }}</ref> [[Glucose]] is the most commonly used osmotic agent and different concentrations of glucose in the dialysis fluid affect the [[ultrafiltration]]. [[Icodextrin]] is a high molecular weight glucose polymer developed as an alternative osmotic agent with slower absorbtion from the peritoneal cavity, facilitating better ultrafiltration.  It is recommended for long dwells in patients with difficulties achieving or maintaining [[euvolemia]]. <ref>{{Cite journal |last1=Wang |first1=Angela Yee Moon |last2=Brimble |first2=K. Scott |last3=Brunier |first3=Gillian |last4=Holt |first4=Stephen G. |last5=Jha |first5=Vivekanand |last6=Johnson |first6=David W. |last7=Kang |first7=Shin-Wook |last8=Kooman |first8=Jeroen P. |last9=Lambie |first9=Mark |last10=McIntyre |first10=Chris |last11=Mehrotra |first11=Rajnish |last12=Pecoits-Filho |first12=Roberto |date=July 2015 |title=ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I – Assessment and Management of Various Cardiovascular Risk Factors |journal=Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis |language=en |volume=35 |issue=4 |pages=379–387 |doi=10.3747/pdi.2014.00279 |pmc=4520720 |pmid=26228782}}</ref>

== History and culture ==
The solution used for peritoneal dialysis is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO21st">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 21st list 2019 | year = 2019 | hdl = 10665/325771 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO | hdl-access=free }}</ref><ref name="WHO22nd">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 22nd list (2021) | year = 2021 | hdl = 10665/345533 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2021.02 | hdl-access=free }}</ref> As of 2009, peritoneal dialysis was available in 12 of 53 African countries.<ref name=Ro2009>{{cite book | veditors = Ronco C, Crepaldi C, Cruz DN |chapter=How to make peritoneal dialysis affordable in developing countries §Peritoneal Dialysis and Economics |title=Peritoneal Dialysis: From Basic Concepts to Clinical Excellence|date=2009|publisher=Karger Medical and Scientific |isbn=978-3-8055-9202-4|page=244|chapter-url=https://books.google.com/books?id=rA8Xo5xEVeoC&pg=PA244}}</ref>

== Medical uses ==
Peritoneal dialysis is a method of [[kidney dialysis|renal replacement therapy]] for those needing maintenance therapy for late stage [[chronic kidney disease]] and is an alternative to the most common method [[hemodialysis]].

==Complications==

=== PD-related peritonitis ===
A common cause of [[peritonitis]] is touch contamination, e.g. insertion of catheter by un-sanitized hands, which potentially introduces bacteria to the abdomen; other causes include catheter complication, transplantation of bowel bacteria, and systemic infections.<ref name=Himmelfarb18 /> Most common type of PD-peritonitis infection (80%) are from bacterial sources.<ref name=Himmelfarb18>{{Cite book| vauthors = Himmelfarb J, Ikizler TA |title=Chronic kidney disease, dialysis, and transplantation : companion to Brenner & Rector's the kidney|isbn=978-0-323-53172-6|chapter=32. Peritoneal Dialysis-Related Infections|oclc=1076544294 |date=2018|publisher=Elsevier Health Sciences }}</ref> Infection rates are highly variable by region and within centers with estimated rates between 0.06–1.66 episodes per patient year.<ref>{{cite journal | vauthors = Cho Y, Johnson DW | title = Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes | language = English | journal = American Journal of Kidney Diseases | volume = 64 | issue = 2 | pages = 278–289 | date = August 2014 | pmid = 24751170 | doi = 10.1053/j.ajkd.2014.02.025 }}</ref> With recent technical advances peritonitis incidence has decreased over time.<ref name=Himmelfarb20 />

Antibiotics are needed if the source of infection is bacterial; there is no clear advantage for other frequently used treatments such as routine peritoneal lavage or use of [[urokinase]].<ref name="Bal2014">{{cite journal | vauthors = Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, Strippoli GF | title = Treatment for peritoneal dialysis-associated peritonitis | journal = The Cochrane Database of Systematic Reviews | issue = 4 | pages = CD005284 | date = April 2014 | pmid = 24771351 | doi = 10.1002/14651858.CD005284.pub3 | pmc = 11231986 }}</ref> The use of preventative nasal [[mupirocin]] is of unclear effect with respect to peritonitis.<ref>{{cite journal | vauthors = Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GF | title = Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients | journal = The Cochrane Database of Systematic Reviews | volume = 4 | pages = CD004679 | date = April 2017 | issue = 6 | pmid = 28390069 | pmc = 6478113 | doi = 10.1002/14651858.CD004679.pub3 }}</ref> Of the three types of connection and fluid exchange systems (standard, twin-bag and y-set; the latter two involving two bags and only one connection to the catheter, the y-set uses a single y-shaped connection between the bags involving emptying, flushing out then filling the peritoneum through the same connection) the twin-bag and y-set systems were found superior to conventional systems at preventing peritonitis.<ref>{{cite journal | vauthors = Daly C, Cody JD, Khan I, Rabindranath KS, Vale L, Wallace SA | title = Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease | journal = The Cochrane Database of Systematic Reviews | issue = 8 | pages = CD003078 | date = August 2014 | volume = 2014 | pmid = 25117423 | pmc = 6457793 | doi = 10.1002/14651858.CD003078.pub2 }}</ref>

The fluid used for dialysis uses [[glucose]] as a primary osmotic agent. According to a 2020 review published in the ''American Journal of Nephrology'', some studies suggest that the use of glucose increases the risk of [[peritonitis]], possibly as a result of impaired host defenses, vascular disease, or damage to the peritoneal membrane.<ref>{{cite journal | last1=Uiterwijk | first1=Herma | last2=Franssen | first2=Casper F.M. | last3=Kuipers | first3=Johanna | last4=Westerhuis | first4=Ralf | last5=Nauta | first5=Ferdau L. | title=Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis | journal=American Journal of Nephrology | publisher=S. Karger AG | volume=51 | issue=3 | year=2020 | doi=10.1159/000506324 | pages=237–243| pmid=32069459 | pmc=7158228 }} "Other studies suggest that a high peritoneal glucose load increases the risk of peritonitis, perhaps as the effect of impaired host defenses, vascular disease, and damage to the peritoneal membrane [9, 10, 11]."</ref> The [[acid]]ity, high concentration and presence of [[Lactic acid|lactate]] and products of the degradation of glucose in the solution (particularly the latter) may contribute to these health issues{{Ambiguous|date=December 2021|reason=which health issues?}}.  Solutions that are [[neutral solution|neutral]], use [[bicarbonate]] instead of lactate and have few glucose degradation products may offer more health benefits though this has not yet been studied.<ref>{{cite journal | vauthors = Perl J, Nessim SJ, Bargman JM | title = The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? | journal = Kidney International | volume = 79 | issue = 8 | pages = 814–824 | date = April 2011 | pmid = 21248712 | doi = 10.1038/ki.2010.515 | doi-access = free }}</ref>

The mortality rate of peritoneal dialysis related peritonitis is estimated to be 3-10%, with approximately 50% of cases resulting in hospitalization.<ref name="Teitelbaum 2021">{{cite journal |last1=Teitelbaum |first1=Isaac |title=Peritoneal Dialysis |journal=New England Journal of Medicine |date=4 November 2021 |volume=385 |issue=19 |pages=1786–95 |doi=10.1056/NEJMra2100152|pmid=34731538 |s2cid=242938564 }}</ref> Peritoneal fluid studies with a white blood cell count greater than 100 per μL and greater than 50% neutrophils strongly suggest peritonitis, with a definitive diagnosis based on culture of microorganisms from the peritoneal fluid.<ref name="Teitelbaum 2021" /> In order to avoid delaying treatment, a cloudy fluid in the dialysate fluid can be assumed to be due to peritonitis unless an alternative cause is identified.<ref name="Teitelbaum 2021" /> Peritonitis in those undergoing PD is usually due to [[gram positive bacteria]].<ref name="Teitelbaum 2021" /> Intraperitoneal antibiotics are preferred to [[intravenous]] as they have a greater effect at the area of infection, unless [[sepsis]] is present, in which case intravenous antibiotics are indicated.<ref name="Teitelbaum 2021" /> The peritoneal dialysis catheter may have to be removed if the infection does not resolve with antibiotics, and it is recommended that the PD catheter be removed in all cases of fungal peritonitis.<ref name="Teitelbaum 2021" />

=== Volume shifts ===
The volume of dialysate removed as well as patient's weight are monitored. If more than 500ml of fluid are retained or a liter of fluid is lost across three consecutive treatments, the patient's physician is generally notified.{{Citation needed|date=December 2021|reason=No reference for physicians being notified.}}  Excessive loss of fluid can result in [[Hypovolemia|hypovolemic shock]] or [[hypotension]] while excessive fluid retention can result in [[hypertension]] and [[edema]].  Also monitored is the color of the fluid removed:  normally it is pink-tinged for the initial four cycles and clear or pale yellow afterward.  The presence of pink or bloody effluent suggests bleeding inside the abdomen while feces indicates a [[Gastrointestinal perforation|perforated bowel]] and cloudy fluid suggests infection.  The patient may also experience pain or discomfort if the dialysate is too acidic, too cold or introduced too quickly, while diffuse pain with cloudy discharge may indicate an infection.  Severe pain in the [[rectum]] or [[perineum]] can be the result of an improperly placed catheter.  The dwell can also increase pressure on the [[thoracic diaphragm|diaphragm]] causing impaired breathing, and [[constipation]] can interfere with the ability of fluid to flow through the catheter.<ref name="Nursing" />

=== Chronic complications ===
Long term use of PD is rarely associated with fibrosis of the peritoneum.<ref name=Himmelfarb20 /> A potentially fatal complication estimated to occur in roughly 2.5% of patients is [[encapsulating peritoneal sclerosis]], in which the bowels become obstructed due to the growth of a thick layer of [[fibrin]] within the peritoneum.<ref>{{cite journal | vauthors = Kawanishi H, Moriishi M | title = Encapsulating peritoneal sclerosis: prevention and treatment | journal = Peritoneal Dialysis International | volume = 27 | issue = Suppl 2 | pages = S289–S292 | date = June 2007 | doi = 10.1177/089686080702702s49 | pmid = 17556321 | s2cid = 1050358 }}</ref>

=== Other ===
Other complications include [[low back pain]] and [[hernia]] or leaking fluid due to high pressure within the abdomen.<ref>{{cite book | vauthors = Himmelfarb J, Ikizler TA |url=http://worldcat.org/oclc/1076544294|title=Chronic kidney disease, dialysis, and transplantation : companion to Brenner & Rector's the kidney|isbn=978-0-323-53172-6|chapter=33. Noninfectious Complications of Peritoneal Dialysis |oclc=1076544294 |date=6 November 2018|publisher=Elsevier Health Sciences }}</ref> [[Hypertriglyceridemia]] and [[obesity]] are also concerns due to the large volume of glucose in the fluid, which can add 500-1200 [[calorie]]s to the diet per day.<ref>{{cite book| vauthors = Ehrman JK, Gordon P, Visich PS, Keteyian SJ |chapter=15. End-Stage Renal Disease §Peritoneal Dialysis |chapter-url= https://books.google.com/books?id=ZKC3_YPMU84C&pg=PA268|title=Clinical Exercise Physiology|publisher=Human Kinetics|year=2008|isbn=978-0-7360-6565-8|pages=268–9}}</ref>

==Method==
Best practices for peritoneal dialysis state that before peritoneal dialysis should be implemented, the person's understanding of the process and support systems should be assessed, with education on how to care for the catheter and to address any gaps in understanding that may exist.  The person should receive ongoing monitoring to ensure adequate dialysis, and be regularly assessed for complications. Finally, they should be educated on the importance of infection control and an appropriate medical regimen established with their cooperation.<ref>{{cite web | url = http://www.cannt.ca/en//files/CANNT_Nursing_Standards_2008.pdf | title = Nephrology Nursing Standards and Practice Recommendations | publisher = Canadian Association of Nephrology Nurses and Technologists | access-date = 2010-09-08 | date = 2008-08-01 | vauthors = Wood M, etal | collaboration = CANNT Nursing Standards Working Group | url-status = dead | archive-url = https://web.archive.org/web/20100331050104/http://www.cannt.ca/en/files/CANNT_Nursing_Standards_2008.pdf | archive-date = 2010-03-31 }}</ref>

<gallery caption="Dialysis process" widths="80px" perrow="5">
File:DP branchement.svg|Hookup
File:DP infusion.svg|Infusion
File:DP stase.svg|Diffusion (fresh)
File:DP fin stase.svg|Diffusion (waste)
File:DP drainage.svg|Drainage
</gallery>

[[File:Blausen 0160 CAPD.png|thumb|right|Continuous Ambulatory Peritoneal Dialysis (CAPD)]]
The abdomen is cleaned in preparation for surgery and a [[catheter]] is surgically inserted with one end in the abdomen and the other protruding from the skin.<ref name="pmid16769289">{{cite journal | vauthors = Harissis HV, Katsios CS, Koliousi EL, Ikonomou MG, Siamopoulos KC, Fatouros M, Kappas AM | title = A new simplified one port laparoscopic technique of peritoneal dialysis catheter placement with intra-abdominal fixation | journal = American Journal of Surgery | volume = 192 | issue = 1 | pages = 125–9 | date = July 2006 | pmid = 16769289 | doi = 10.1016/j.amjsurg.2006.01.033 }}</ref> Catheters can also be inserted without a general anaesthetic by a physician using a needle, known as a medical insertion. Both methods have similar safety profiles.<ref>{{Cite journal |last1=Fotheringham |first1=James |last2=Solis-Trapala |first2=Ivonne |last3=Briggs |first3=Victoria |last4=Lambie |first4=Mark |last5=McCullough |first5=Keith |last6=Dunn |first6=Louese |last7=Rawdin |first7=Andrew |last8=Hill |first8=Harry |last9=Wailloo |first9=Allan |last10=Davies |first10=Simon |last11=Wilkie |first11=Martin |date=2023-12-01 |title=Catheter Event Rates in Medical Compared to Surgical Peritoneal Dialysis Catheter Insertion |url=https://doi.org/10.1016/j.ekir.2023.09.015 |journal=Kidney International Reports |volume=8 |issue=12 |pages=2635–45 |doi=10.1016/j.ekir.2023.09.015 |pmc=10719604 |pmid=38106573}}</ref><ref>{{Cite journal |date=9 April 2024 |title=Kidney failure: medical insertion of catheters for peritoneal dialysis is as safe as surgery |url=https://evidence.nihr.ac.uk/alert/kidney-failure-medical-insertion-of-catheters-for-peritoneal-dialysis-is-as-safe-as-surgery/ |journal=NIHR Evidence|doi=10.3310/nihrevidence_62664 |url-access=subscription }}</ref> Before each infusion the catheter must be cleaned, and flow into and out of the abdomen tested.  2-3 liters of dialysis fluid is introduced into the abdomen over the next ten to fifteen minutes.<ref name = Nursing/>  The total volume is referred to as a ''dwell''<ref name = Crowley2009/> while the fluid itself is referred to as dialysate.  The dwell can be as much as 3 liters, and medication can also be added to the fluid immediately before infusion.<ref name = Nursing>{{cite book | vauthors = Munden J |title=Best practices : evidence-based nursing procedures. |date=2007 |publisher=Lippincott Williams & Wilkins |location=Philadelphia |isbn=978-1-58255-532-4 |edition=2nd | url = https://archive.org/details/bestpracticesevi0000unse}}</ref> The dwell remains in the abdomen and waste products diffuse across the peritoneum from the underlying blood vessels.  After a variable period of time depending on the treatment (usually 4–6 hours<ref name = Nursing/> ), the fluid is removed and replaced with fresh fluid.  This can occur automatically while the patient is sleeping (automated peritoneal dialysis, APD), or during the day by keeping two litres of fluid in the abdomen at all times, exchanging the fluids four to six times per day (continuous ambulatory peritoneal dialysis, CAPD).<ref name=Crowley2009>{{cite book | vauthors = Crowley LV | year = 2009 | publisher = Jones & Bartlett | isbn = 978-0-7637-6591-0 | title = An Introduction to Human Disease: Pathology and Pathophysiology Correlations | url = https://books.google.com/books?id=TEiuWP4z_QIC&pg=PA507 | pages = 507–9 | url-status = live | archive-url = https://web.archive.org/web/20130618122928/http://books.google.com/books?id=TEiuWP4z_QIC&pg=PA507 | archive-date = 2013-06-18 }}</ref><ref name = McPhee2007>{{cite book | vauthors = McPhee SJ, Tierney LM, Papadakis MA |chapter=Dialysis | title = Current medical diagnosis and treatment | year = 2007 | isbn = 978-0-07-147247-0 | publisher = [[McGraw-Hill]] | pages = 934–5 }}</ref>

The fluid used typically contains [[sodium chloride]], [[Lactic acid|lactate]] or [[bicarbonate]] and a high percentage of [[glucose]] to ensure [[osmolarity|hyperosmolarity]].  The amount of dialysis that occurs depends on the volume of the dwell, the regularity of the exchange and the concentration of the fluid. APD cycles between 3 and 10 dwells per night, while CAPD involves four dwells per day of 2-3 liters per dwell, with each remaining in the abdomen for 4–8 hours.  The viscera accounts for roughly four-fifths of the total surface area of the membrane, but the parietal peritoneum is the most important of the two portions for PD.  Two complementary models explain dialysis across the membrane — the three-pore model (in which molecules are exchanged across membranes which sieve molecules, either [[protein]]s, electrolytes or water, based on the size of the pores) and the distributed model (which emphasizes the role of [[capillary|capillaries]] and the solution's ability to increase the number of active capillaries involved in PD).  The high concentration of glucose drives the filtration of fluid by osmosis (osmotic UF) from the peritoneal capillaries to the peritoneal cavity. Glucose diffuses rather rapidly from the dialysate to the blood (capillaries). After 4-6 h of the dwell, the glucose osmotic gradient usually becomes too low to allow for further osmotic UF. Therefore, the dialysate will now be reabsorbed from the peritoneal cavity to the capillaries by means of the plasma colloid osmotic pressure, which exceeds the colloid osmotic pressure in the peritoneum by approximately 18-20 mmHg (cf. the Starling mechanism).<ref name="pmid15104333">{{cite journal | vauthors = Rippe B, Venturoli D, Simonsen O, de Arteaga J | title = Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model | journal = Peritoneal Dialysis International | volume = 24 | issue = 1 | pages = 10–27 | date = 2004 | pmid = 15104333 | doi = 10.1177/089686080402400102 | s2cid = 25034246 }}</ref> Lymphatic absorption will also to some extent contribute to the reabsorption of fluid from the peritoneal cavity to the plasma. Patients with a high water permeability (UF-coefficient) of the peritoneal membrane can have an increased reabsorption rate of fluid from the peritoneum by the end of the dwell. The ability to exchange small solutes and fluid in-between the peritoneum and the plasma can be classified as high (fast), low (slow) or intermediate.  High transporters tend to diffuse substances well (easily exchanging small molecules between blood and the dialysis fluid, with somewhat improved results with frequent, short-duration dwells such as with APD), while low transporters have a higher UF (due to the slower reabsorption of glucose from the peritoneal cavity, which results in somewhat better results with long-term, high-volume dwells), though in practice either type of transporter can generally be managed through the appropriate use of either APD or CAPD.<ref name=Daugirdas2006>{{cite book | vauthors = Daugirdas JT, Blake PG, Ing TS | year = 2006 | title = Handbook of dialysis | publisher = Lippincott Williams & Wilkins | chapter-url = https://books.google.com/books?id=IGV4boOFjZYC&pg=PA323 | page = 323 | chapter = Physiology of Peritoneal Dialysis | isbn = 978-0-7817-5253-4 | url-status = live | archive-url = https://web.archive.org/web/20130618180548/http://books.google.com/books?id=IGV4boOFjZYC&pg=PA323 | archive-date = 2013-06-18 }}</ref>

Though there are several different shapes and sizes of catheters that can be used, different insertion sites, number of cuffs in the catheter and immobilization, there is no evidence to show any advantages in terms of morbidity, mortality or number of infections, though the quality of information is not yet sufficient to allow for firm conclusions.<ref>{{cite journal | vauthors = Htay H, Johnson DW, Craig JC, Schena FP, Strippoli GF, Tong A, Cho Y | title = Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients | journal = The Cochrane Database of Systematic Reviews | volume = 2019 | pages = CD004680 | date = May 2019 | issue = 5 | pmid = 31149735 | pmc = 6543877 | doi = 10.1002/14651858.CD004680.pub3 }}</ref>

A [[peritoneal equilibration test]] may be done to assess a person for peritoneal dialysis by determining the characteristics of the peritoneal membrane mass transport characteristics.

=== Improvised dialysis ===
Peritoneal dialysis can be improvised in conditions such as combat surgery or disaster relief using surgical catheters and dialysate made from routinely available medical solutions to provide temporary renal replacement for people with no other options.<ref>{{cite journal | vauthors = Pina JS, Moghadam S, Cushner HM, Beilman GJ, McAlister VC | title = In-theater peritoneal dialysis for combat-related renal failure | journal = The Journal of Trauma | volume = 68 | issue = 5 | pages = 1253–56 | date = May 2010 | pmid = 20453775 | doi = 10.1097/TA.0b013e3181d99089 | s2cid = 24251777 | url = https://works.bepress.com/cgi/viewcontent.cgi?article=1043&context=vivianmcalister }}</ref>

==Epidemiology==
As of 2017, hemodialysis is the most widely available renal replacement modality found in 96% of countries whereas peritoneal dialysis (PD) is only available in 75% of countries.<ref name=Himmelfarb20>{{cite journal | vauthors = Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M | title = The current and future landscape of dialysis | journal = Nature Reviews. Nephrology | volume = 16 | issue = 10 | pages = 573–585 | date = October 2020 | pmid = 32733095 | pmc = 7391926 | doi = 10.1038/s41581-020-0315-4 }}</ref> In 2016, the proportion of people receiving peritoneal dialysis (PD) was estimated at 11% with wide differences between different countries and regions.<ref name=Li17>{{cite journal | vauthors = Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, Lameire N | display-authors = 6 | title = Changes in the worldwide epidemiology of peritoneal dialysis | journal = Nature Reviews. Nephrology | volume = 13 | issue = 2 | pages = 90–103 | date = February 2017 | pmid = 28029154 | doi = 10.1038/nrneph.2016.181 | s2cid = 25054210 }}</ref> In Hong Kong and [[Mexico]], PD is more common than the world average, with Mexico conducting most of its dialysis through PD, while [[Japan]] and [[Germany]] have rates lower than the world average.<ref>{{cite journal | vauthors = Grassmann A, Gioberge S, Moeller S, Brown G | title = ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends | journal = Nephrology, Dialysis, Transplantation | volume = 20 | issue = 12 | pages = 2587–93 | date = December 2005 | pmid = 16204281 | doi = 10.1093/ndt/gfi159 | doi-access = free }}</ref> Peritoneal dialysis first models, patients requiring renal replacement therapy are placed on PD first, and financial incentives for using PD are associated with increase uptake of PD in multiple countries.<ref name=Li17 />

=== East and Southeast Asia ===
Hong Kong has the highest rate of PD use worldwide at 71.9% in 2014, while in Mainland China had 20% in 2014, 23% in Thailand during 2012, and 10-20% in Vietnam during 2011.<ref name=Li17 /> Hong Kong had a PD-first model since 1985, Thailand began a PD-first model since 2008 which increased their levels of PD from <10%.<ref name=Li17 />

=== Americas ===
Prevalence in of PD use was 9.7% in USA during 2013 and 16.3% in Canada during 2013.<ref name=Li17 /> The lower PD rates in the USA are due to higher availability of large corporate owned hemodialysis centers. There have been recent increase in PD uptake in the USA due to changes to Medicare reimbursement such as [[bundled payment]] for dialysis this incentivizes use of PD which is a less costly modality for dialysis.<ref name=Li17 />

Overall, prevalence of PD use is 24.6% in Latin America during 2011.<ref name=Li17 /> Within Latin America, hemodialysis has a higher growth rate in use compared to PD between 1994–2010. In 2010, the most prevalent use of PD were in Mexico 55.9% and El Salvador 67.6%. Between 2000–2010, Colombia's PD rate dropped from 54% to 31.3%.<ref>{{cite journal | vauthors = Rosa-Diez G, Gonzalez-Bedat M, Pecoits-Filho R, Marinovich S, Fernandez S, Lugon J, Poblete-Badal H, Elgueta-Miranda S, Gomez R, Cerdas-Calderon M, Almaguer-Lopez M, Freire N, Leiva-Merino R, Rodriguez G, Luna-Guerra J, Bochicchio T, Garcia-Garcia G, Cano N, Iron N, Cuero C, Cuevas D, Tapia C, Cangiano J, Rodriguez S, Gonzalez H, Duro-Garcia V | display-authors = 6 | title = Renal replacement therapy in Latin American end-stage renal disease | journal = Clinical Kidney Journal | volume = 7 | issue = 4 | pages = 431–6 | date = August 2014 | pmid = 25349696 | pmc = 4208784 | doi = 10.1093/ckj/sfu039 }}</ref>

== History ==
Peritoneal dialysis was first carried out in the 1920s; however, long-term use did not come into medical practice until the 1960s.<ref name=Nolph>{{cite book| vauthors = Nolph KD |title=Peritoneal dialysis|date=2013-03-09|publisher=Springer |isbn=978-94-017-2560-6|page=1.0 and 2.0|language=en|chapter=History of peritoneal dialysis|chapter-url=https://books.google.com/books?id=w1aHBwAAQBAJ&pg=PT33|archive-url=https://web.archive.org/web/20170113133408/https://books.google.ca/books?id=w1aHBwAAQBAJ&pg=PT33|archive-date=2017-01-13|url-status=live}}</ref> The timeline was
* 1923 – [[Georg Ganter]] performs the first peritoneal dialysis in a [[guinea pig]] and attempts the procedure in humans, without success. [[Hypertonic saline]] was used as the dialysate.<ref name=Nolph/><ref name=Misra>{{cite journal| vauthors=Misra M, Phadke GM| title=Historical milestones in peritoneal dialysis | journal=Contrib Nephrol | series=Contributions to Nephrology | year= 2019 | volume= 197 | issue=  | pages= 1–8 | pmid=34569508 | doi=10.1159/000496301| isbn=978-3-318-06476-6 | doi-access=free }}</ref>
* 1927 – [[Heinrich Heusser]] and [[Hermann Werder]] were the first to treat 3 patients with continuous flow PD using two catheters. They demonstrated a decrease in the levels of blood urea, but did not suceed clinically.<ref>María Mercedes Moreiras-Plaza: ''[https://www.revistanefrologia.com/index.php?p=revista&tipo=pdf-simple&pii=X2013251414054808 Where we come from and where we are going in terms of peritoneal dialysis: identifying barriers and strategies for the future]''; Nefrologia 5/2014: 545</ref>
* 1946 – Howard Frank, Arnold Seligman, and Jacob Fine of [[Beth Israel Deaconess Medical Center|Beth Israel Hospital]] in [[Boston]] report the first successful use of peritoneal dialysis in clinical practice,<ref name=Misra/> in a 51-year-old man with acute renal failure caused by [[sulfathiazole]] poisoning.<ref>{{cite journal| vauthors=Frank HA, Seligman AM, Fine J| title=Treatment of uremia after acute renal failure by peritoneal irrigation | journal=J Am Med Assoc | year= 1946 | volume= 130 | issue=11 | pages= 703–5 | pmid=21016282 | doi=10.1001/jama.1946.02870110027008a}}</ref>
* 1959 – Paul Doolan and Richard Ruben of [[Naval Hospital Oakland]] first use peritoneal dialysis to treat end-stage renal disease, in a 33-year-old woman named Willie Mae Stewart. After 6 months of intermittent dialysis, she declines further treatment due to complications and dies in June 1960.<ref name=Drukker>{{cite book | last1=Drukker | first1=William | last2=Parsons | first2=Frank M. | last3=Maher | first3=J.F. | title=Replacement of Renal Function by Dialysis | publisher=Springer Science & Business Media | date=2012-12-06 | isbn=978-94-009-6768-7 | pages=422–3}}</ref>
* 1964–1965 – [[Henry Tenckhoff]], G. Shilipetar and [[Fred Boen]] of the [[University of Washington]] report the first case of home peritoneal dialysis, with long-term success despite technical difficulties and a burdensome process.<ref name=Drukker/><ref>{{cite journal |vauthors=Tenckhoff H, Shilipetar G, Boen ST |title=One year's experience with home peritoneal dialysis |journal=Trans Am Soc Artif Intern Organs |volume=11 |issue= |pages=11–7 |date=1965 |pmid=14329068 |doi=10.1097/00002480-196504000-00004}}</ref>
* 1968 – Henry Tenckhoff creates the [[Tenckhoff catheter]], avoiding the need to replace the catheter in the abdomen at every treatment.<ref>{{cite journal | vauthors = Mehrotra R, Devuyst O, Davies SJ, Johnson DW | title = The Current State of Peritoneal Dialysis | journal = Journal of the American Society of Nephrology | volume = 27 | issue = 11 | pages = 3238–52 | date = November 2016 | pmid = 27339663 | pmc = 5084899 | doi = 10.1681/ASN.2016010112 }}</ref>

== Comparison to hemodialysis ==
Compared to hemodialysis, peritoneal dialysis (PD) has several potential advantages: it allows greater lifestyle flexibility for patients, may preserve residual kidney function to a greater extent, and produces fewer changes in blood pressure due to the continuous nature of fluid removal, thus making it more suitable for patients with [[cardiorenal syndrome]] or [[Cardiac arrhythmia|cardiac instability]].<ref>Jung HY, Jeon Y, Park Y, et al. Better Quality of Life of Peritoneal Dialysis compared to Hemodialysis over a Two-year Period after Dialysis Initiation. ''Scientific Reports''. 2019;9(1):10266. doi:[https://doi.org/10.1038/s41598-019-46744-1 10.1038/s41598-019-46744-1]</ref><ref>Auguste BL, Agarwal A, Ibrahim AZ, et al. A Single-Center Retrospective Study on the Initiation of Peritoneal Dialysis in Patients With Cardiorenal Syndrome and Subsequent Hospitalizations. ''Canadian Journal of Kidney Health and Disease''. 2020;7:2054358120979239. doi:[https://doi.org/10.1177/2054358120979239 10.1177/2054358120979239]</ref> Also, [[phosphate]] compounds are better removed on PD, but large amounts of [[albumin]] are removed which requires constant monitoring of nutritional status.<ref name=Himmelfarb20 />

PD also has potential disadvantages, including a higher risk of [[dyslipidemia]], a tendency to exacerbate [[hyperglycemia]] (due to the exogenous glucose load) and additional responsibilities for patients and families.<ref>Sinnakirouchenan R, Safi M, Patel P. Peritoneal Dialysis Versus Hemodialysis: Risks, Benefits, and Access Issues. ''Advances in Chronic Kidney Disease''. 2011;18(6):428–432. doi:[https://doi.org/10.1053/j.ackd.2011.07.002 10.1053/j.ackd.2011.07.002]</ref>

The costs of PD are generally lower than those of HD in most parts of the world, this cost advantage is most apparent in high-income countries.<ref>{{cite journal | vauthors = Karopadi AN, Mason G, Rettore E, Ronco C | title = Cost of peritoneal dialysis and haemodialysis across the world | journal = Nephrology, Dialysis, Transplantation | volume = 28 | issue = 10 | pages = 2553–69 | date = October 2013 | pmid = 23737482 | doi = 10.1093/ndt/gft214 | veditors = Zoccali C | doi-access = free | citeseerx = 10.1.1.1026.3780 }}</ref> There is insufficient research to adequately compare the risks and benefits between CAPD and APD; a [[Cochrane Collaboration|Cochrane Review]] of three small [[clinical trial]]s found no difference in clinically important outcomes (i.e. [[Disease#Morbidity|morbidity]] or [[Mortality rate|mortality]]) for patients with [[Chronic kidney disease|end stage renal disease]], nor was there any advantage in preserving the functionality of the kidneys.  The results suggested APD may have psychosocial advantages for younger patients and those who are employed or pursuing an education.<ref>{{cite journal |vauthors=Driehuis E, Eshuis M, Abrahams A, François K, Vernooij RW |title=Automated peritoneal dialysis versus continuous ambulatory peritoneal dialysis for people with kidney failure |journal=Cochrane Database Syst Rev |volume=11 |issue=9 |pages=CD006515 |date=September 2024 |pmid=39258519 |doi=10.1002/14651858.CD006515.pub2 }}</ref>

== Society and culture ==
=== Economics ===
The cost of dialysis treatment is related to how wealthy the country is.<ref name=Ro2009/> In the United States peritoneal dialysis costs the government about $53,400 per person per year.<ref name = "Lim_2016">{{cite journal | vauthors = Lim K, Palsson R, Siedlecki A |title=Dialysis Initiation During the Hospital Stay |journal=Hospital Medicine Clinics |date=October 2016 |volume=5 |issue=4 |pages=467–477 |doi=10.1016/j.ehmc.2016.05.008}}</ref>

== References ==
{{reflist}}

== External links ==
{{commons category|Peritoneal dialysis}}
*{{cite web |title=Treatment Methods for Kidney Failure |date= |publisher=[[National Institute of Diabetes and Digestive and Kidney Diseases]] |url=https://web.archive.org/web/20110608142530/http://kidney.niddk.nih.gov/kudiseases/pubs/kidneyfailure/index.htm }}

{{Digestive system procedures}}
{{Portal bar|Medicine}}

{{DEFAULTSORT:Peritoneal Dialysis}}
[[Category:Digestive system procedures]]
[[Category:Medical treatments]]
[[Category:Renal dialysis]]
[[Category:World Health Organization essential medicines]]
[[Category:Wikipedia medicine articles ready to translate]]

[[de:Dialyse#Peritonealdialyse]]